Ling Liu
Impact in
- Immunology top 2%
- Atherosclerosis and Cardiovascular Diseases
- Psoriasis: Treatment and Pathogenesis
- Cancer Research top 2%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
Papers in
-
- MicroRNA in disease regulation 19
- Cancer, Lipids, and Metabolism 14
-
- Lipid metabolism and disorders 18
- Co-authors
- Shui‐Ping ZhaoKristine KiklyTianru JinXiaoyan ZhengDayuan LiHongjiang ChenJawahar L. MehtaTatsuya Sawamura
- Journals
- Frontiers in Cardiovascular Medicine (8 papers)International Journal of Cardiology (5 papers)Coronary Artery Disease (5 papers)PLoS ONE (5 papers)Frontiers in Cell and Developmental Biology (4 papers)
- Partner nations
- ChinaUnited StatesCanada
In The Last Decade
Ling Liu
391 papers receiving 8.3k citations
Hit Papers
Peers
Comparison fields: 5 of 177
- Immunology 1.4k
- Cancer Research 1000
- Molecular Biology 3.1k
- Biological Psychiatry 96
- Neurology 297
Countries citing papers authored by Ling Liu
This map shows the geographic impact of Ling Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ling Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ling Liu more than expected).
Fields of papers citing papers by Ling Liu
This network shows the impact of papers produced by Ling Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ling Liu. The network helps show where Ling Liu may publish in the future.
Co-authors
The 25 scholars most cited alongside Ling Liu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 2 | |
| 3 | 2025 | 1 | |
| 4 | 2025 | 2 | |
| 5 | 2024 | 1 | |
| 6 | 2024 | 5 | |
| 7 | 2024 | 1 | |
| 8 | 2024 | 2 | |
| 9 | 2023 | 15 | |
| 10 | 2023 | 0 | |
| 11 | 2023 | 13 | |
| 12 | 2023 | 5 | |
| 13 | 2023 | 3 | |
| 14 | 2021 | 18 | |
| 15 | 2019 | 14 | |
| 16 | 2019 | 1 | |
| 17 | 2018 | 14 | |
| 18 | Efficacy and safety of rt-PA intravenous thrombolysis for treating acute ischemic stroke beyond the therapeutic window: a Meta-analysis | 2016 | 1 |
| 19 | [Role of PI3K/Akt pathway in effect of paeoniflorin against Aβ25-35-induced PC12 cell injury]. | 2014 | 3 |
| 20 | 1999 | 41 |
About Ling Liu
Ling Liu is a scholar working on Cancer Research, Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism, Immunology and Epidemiology, having authored 415 papers that have together received 8.4k indexed citations. Recurring topics across this work include Lipoproteins and Cardiovascular Health (28 papers), Adipokines, Inflammation, and Metabolic Diseases (22 papers), Atherosclerosis and Cardiovascular Diseases (22 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (22 papers), MicroRNA in disease regulation (19 papers), Lipid metabolism and disorders (18 papers), Cancer, Lipids, and Metabolism (14 papers) and Circular RNAs in diseases (13 papers). The work is most often cited by research in Immunology (1.4k citations), Cancer Research (1000 citations), Molecular Biology (3.1k citations), Biological Psychiatry (96 citations) and Neurology (297 citations). Ling Liu has collaborated with scholars based in China, United States and Canada. Frequent co-authors include Shui‐Ping Zhao, Kristine Kikly, Tianru Jin, Xiaoyan Zheng, Dayuan Li, Hongjiang Chen, Jawahar L. Mehta, Tatsuya Sawamura, Benjin Xu and Songqing Na. Their work appears in journals such as Frontiers in Cardiovascular Medicine, International Journal of Cardiology, Coronary Artery Disease, PLoS ONE and Frontiers in Cell and Developmental Biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.